Twist Bioscience Corporation
TWST
$29.70
-$0.16-0.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.07% | 3.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.07% | 3.52% | |||
| Cost of Revenue | 7.62% | -4.29% | |||
| Gross Profit | -0.90% | 11.45% | |||
| SG&A Expenses | 0.61% | -0.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.19% | -6.09% | |||
| Operating Income | 0.62% | 27.53% | |||
| Income Before Tax | -230.61% | 152.57% | |||
| Income Tax Expenses | 34.55% | 9.14% | |||
| Earnings from Continuing Operations | -233.09% | 151.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -233.09% | 151.85% | |||
| EBIT | 0.62% | 27.53% | |||
| EBITDA | -11.54% | 31.58% | |||
| EPS Basic | -232.13% | 151.55% | |||
| Normalized Basic EPS | 5.60% | 28.21% | |||
| EPS Diluted | -236.09% | 150.05% | |||
| Normalized Diluted EPS | 3.74% | 29.60% | |||
| Average Basic Shares Outstanding | 0.72% | 0.58% | |||
| Average Diluted Shares Outstanding | -1.21% | 2.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||